Bartosz Hudzik: Extended Anticoagulation in Cancer-Associated VTE – Who Is at Higher Bleeding Risk?
Bartosz Hudzik, Editorial Consultant at JACC Case Reports, shared on LinkedIn about a recent article by Isabelle Mahé et al, published in The Lancet Haematology:
”Extended anticoagulation in cancer-associated VTE: who is at higher bleeding risk?
Extended anticoagulation with reduced-dose apixaban has been shown to be non-inferior to full-dose therapy for preventing recurrent VTE in patients with active cancer—while offering fewer clinically relevant bleeding events.
A new post-hoc analysis of the API-CAT trial takes a closer look at predictors of clinically relevant bleeding during extended therapy.
Key findings (12-month follow-up, n=1,766):
Four factors were independently associated with increased bleeding risk:
• Anaemia and/or thrombocytopenia
• Age ≥75 years
• Pulmonary embolism as the index event
• Male sex
Notably:
• Results were consistent across cancer types
• No interaction with apixaban dose was observed
Why this matters
Although API-CAT was not designed to guide anticoagulation discontinuation, these insights may help clinicians better individualize extended anticoagulation, balancing thrombotic protection against bleeding risk in patients with cancer-associated VTE.”
Title: Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial
Authors: Isabelle Mahé, Céline Chapelle, Philippe Girard, Marc Carrier, Luis Jara Palomares, Charles-Marc Samama, Hélène Helfer, Grigoris Gerotziafas, Silvy Laporte, Eric Vicaut, Patrick Mismetti for the API-CAT Study Group and API-CAT Investigators
Read the Full Article on The Lancet Haematology
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 4, 2026, 08:07Fayad Al-Haimus: Is Giving TXA Within ‘3 Hours’ Really Enough in Major Trauma?
-
Feb 4, 2026, 08:05Stephen Cornelissen Honors the Life-Saving Impact of Blood Donation on World Cancer Day
-
Feb 4, 2026, 07:55Louise St Germain Bannon: Proud to Share This Important Constituency Statement Delivered at EB158
-
Feb 4, 2026, 07:45Laure Morimont and Colleagues on Early Prediction of VTE Risk with COCs
-
Feb 4, 2026, 07:29Heghine Khachatryan: Behind These Photos Are Not Just Official Meetings…
-
Feb 3, 2026, 17:50Allen Seylani: A Small RNA With a Big Grip on Cholesterol and Heart Disease
-
Feb 3, 2026, 17:39Breaking News from WHO Executive Board Session in Geneva – WFH
-
Feb 3, 2026, 17:26Francesco Lo Monaco: When Calcium Goes to the Wrong Place – Vitamin K and the Mechanisms of Vascular Calcification
-
Feb 3, 2026, 17:18Khalid Ahmed: The HALO Study to Understand Quality of Life After Childhood Hematological Disorders